Stocks Health care HYPR
NASDAQ · Health careHyperfine, Inc. (HYPR)
Hyperfine, Inc. brought in $16.5M of revenue over the twelve months to June 30, 2026, up 53.2% from a year earlier. It posted a net loss of $34.9M. In fiscal 2025 capital spending exceeded operating cash flow by $29.1M. At June 30, 2026 it held $43.5M in cash against $13.2M of debt. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 6, 2026.
Key facts about Hyperfine, Inc.
- Net worth
- Hyperfine, Inc. has a market value (market cap) of $72.2M at the latest share price, and shareholders' equity of $36.8M on its balance sheet at June 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
- Revenue and profit
- In fiscal 2025 revenue was $13.6M (+5.2% year on year), with a net loss of $35.6M. Over the 12 months to June 30, 2026: revenue $16.5M, net loss $34.9M.
- Cash flow
- In fiscal 2025 operations used $27.9M of cash.
- Latest report
- The latest periodic report (quarterly report, 10-Q) was filed with the SEC on August 6, 2026 and covers the period to June 30, 2026. Open on SEC EDGAR
- Next earnings report
- Hyperfine, Inc.'s next report was expected around October 14, 2026 and is not on file with the SEC yet.
What Hyperfine, Inc. does
Hyperfine, Inc. is registered with the SEC under industry code SIC 3845 (Electromedical & Electrotherapeutic Apparatus). Its shares trade on NASDAQ under the ticker HYPR.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $13.6M | -$35.6M | -$0.43 | -$29.1M |
| 2024 | $12.9M | -$40.7M | -$0.56 | -$39.2M |
| 2023 | $11M | -$44.2M | -$0.62 | -$42.6M |
| 2022 | $6.8M | -$44.2M | -$1.04 | -$72.9M |
| 2021 | $1.5M | -$64.9M | -$17.57 | -$49.9M |
| 2021 | $294K | -$23.4M | -$15.38 | -$23.1M |
Earnings: every quarter and the next report date
Full financial statements: income, balance sheet and cash flow
Where HYPR ranks in Health care
Latest SEC filings
What Hyperfine, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- September 18, 2026
- August 6, 2026Quarterly report 10-Q · period to June 30, 2026Revenue rose 45% to $3.9M versus the same quarter last year; diluted EPS -$0.09 versus -$0.12.
- August 6, 2026
- July 28, 2026Passive stake (5% or more) SCHEDULE 13G
- May 21, 2026
- May 12, 2026
- May 12, 2026Quarterly report 10-Q · period to March 31, 2026Revenue rose 83% to $3.9M versus the same quarter last year; diluted EPS -$0.09 versus -$0.12.
- May 12, 2026
- April 8, 2026
- April 8, 2026Additional proxy material DEFA14A
Insider trades
What the people running Hyperfine, Inc. did with its shares, from the Form 4 filings they must send the SEC within two business days.
Insiders sold $12.5K worth of shares in the last 90 days and bought none on the open market.
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| August 24, 2026 | Hale BrettCFO and CAO | Sold | 7,345 | $6.3K |
| August 24, 2026 | Teisseyre ThomasChief Operating Officer | Sold | 7,345 | $6.3K |
| May 26, 2026 | Teisseyre ThomasChief Operating Officer | Sold | 6,047 | $10K |
| May 26, 2026 | Hale BrettCFO and CAO | Sold | 6,047 | $10K |
| March 31, 2026 | Sainz MariaPresident and CEO, Director | Received as pay | 750,000 | - |
| March 31, 2026 | Teisseyre ThomasChief Operating Officer | Received as pay | 330,000 | - |
| March 31, 2026 | Hale BrettCFO and CAO | Received as pay | 330,000 | - |
| March 23, 2026 | Hale BrettCFO and CAO | Sold | 24,188 | $29.3K |
Who owns HYPR
Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.
5% holders
Largest institutional holders
Insiders
3 insiders reported holding 2,053,262 shares in total, about $1.4M at the last price.
| Holder | Shares |
|---|---|
| Sainz MariaPresident and CEO, Director | 789,586 |
| Teisseyre ThomasChief Operating Officer | 671,256 |
| Hale BrettCFO and CAO | 592,420 |
Questions about HYPR
What does Hyperfine, Inc. do?
Hyperfine, Inc. is a company in the Health care sector, listed on NASDAQ as HYPR. Its shares trade on NASDAQ under the ticker HYPR.
What is Hyperfine, Inc.'s net worth?
Hyperfine, Inc. has a market value (market cap) of $72.2M at the latest share price, and shareholders' equity of $36.8M on its balance sheet at June 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Is Hyperfine, Inc. profitable?
No. Over the twelve months to June 30, 2026 it reported a net loss of $34.9M on revenue of $16.5M.
How much revenue does Hyperfine, Inc. make?
Over the twelve months to June 30, 2026 Hyperfine, Inc. reported revenue of $16.5M. That is 53.2% more than a year earlier.
When did Hyperfine, Inc. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on August 6, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the stock exchange listing notice from September 18, 2026.
When is Hyperfine, Inc.'s next earnings report?
Hyperfine, Inc.'s next report was expected around October 14, 2026 and is not on file with the SEC yet.
Similar companies
Compare HYPR with
Follow HYPR
Get an email when Hyperfine, Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Where the numbers come from
Financial figures are the values Hyperfine, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.